Skip to main content

5 March 2026

Last updated: Tuesday 3 March 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Innate Pharma's anti-cancer platform attracts BMS investment

Friday 15 July 2011

Interviewee/Contributor

Herve Brailly

Organisation

Innate Pharma SA

Organisations

Bellevue Asset Management
GE Healthcare
NDA Group
Simmons and Simmons LLP
Innovative Medicines Initiative
Pulse Infoframe Inc
Life Sciences Partners BV
Progenitor Labs Ltd
Wellcome Trust
DCPrime BV

Interviewees and Contributers

Paul Higham
Dr Jochen Klupp
Frederic Triebel
Clementine Brooks and Amy Ellington
Rob Meijer
Jonathan Frampton
Will West
Alfred Scheidegger
Philip Vanek
Heinz Schwer

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

VoxCell appoints CCO

Saturday 28 February 2026

Qlaris Bio appoints board director

Saturday 28 February 2026

Clarametyx adds four experts to SAB

Saturday 28 February 2026

Enhanced Genomics appoints Katerina Leftheris to board

Saturday 28 February 2026

New COO at Qureight

Saturday 28 February 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form